Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils

Abstract Examination of early phases of synucleinopathy when inclusions are present, but long before neurodegeneration occurs, is critical to both understanding disease progression and the development of disease modifying therapies. The rat alpha-synuclein (α-syn) preformed fibril (PFF) model induce...

Full description

Bibliographic Details
Main Authors: Joseph R. Patterson, Joseph Kochmanski, Anna C. Stoll, Michael Kubik, Christopher J. Kemp, Megan F. Duffy, Kajene Thompson, Jacob W. Howe, Allyson Cole-Strauss, Nathan C. Kuhn, Kathryn M. Miller, Seth Nelson, Christopher U. Onyekpe, John S. Beck, Scott E. Counts, Alison I. Bernstein, Kathy Steece-Collier, Kelvin C. Luk, Caryl E. Sortwell
Format: Article
Language:English
Published: Nature Portfolio 2024-01-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-023-00620-y
_version_ 1797363518870126592
author Joseph R. Patterson
Joseph Kochmanski
Anna C. Stoll
Michael Kubik
Christopher J. Kemp
Megan F. Duffy
Kajene Thompson
Jacob W. Howe
Allyson Cole-Strauss
Nathan C. Kuhn
Kathryn M. Miller
Seth Nelson
Christopher U. Onyekpe
John S. Beck
Scott E. Counts
Alison I. Bernstein
Kathy Steece-Collier
Kelvin C. Luk
Caryl E. Sortwell
author_facet Joseph R. Patterson
Joseph Kochmanski
Anna C. Stoll
Michael Kubik
Christopher J. Kemp
Megan F. Duffy
Kajene Thompson
Jacob W. Howe
Allyson Cole-Strauss
Nathan C. Kuhn
Kathryn M. Miller
Seth Nelson
Christopher U. Onyekpe
John S. Beck
Scott E. Counts
Alison I. Bernstein
Kathy Steece-Collier
Kelvin C. Luk
Caryl E. Sortwell
author_sort Joseph R. Patterson
collection DOAJ
description Abstract Examination of early phases of synucleinopathy when inclusions are present, but long before neurodegeneration occurs, is critical to both understanding disease progression and the development of disease modifying therapies. The rat alpha-synuclein (α-syn) preformed fibril (PFF) model induces synchronized synucleinopathy that recapitulates the pathological features of Parkinson’s disease (PD) and can be used to study synucleinopathy progression. In this model, phosphorylated α-syn (pSyn) inclusion-containing neurons and reactive microglia (major histocompatibility complex-II immunoreactive) peak in the substantia nigra pars compacta (SNpc) months before appreciable neurodegeneration. However, it remains unclear which specific genes are driving these phenotypic changes. To identify transcriptional changes associated with early synucleinopathy, we used laser capture microdissection of the SNpc paired with RNA sequencing (RNASeq). Precision collection of the SNpc allowed for the assessment of differential transcript expression in the nigral dopamine neurons and proximal glia. Transcripts upregulated in early synucleinopathy were mainly associated with an immune response, whereas transcripts downregulated were associated with neurotransmission and the dopamine pathway. A subset of 29 transcripts associated with neurotransmission/vesicular release and the dopamine pathway were verified in a separate cohort of males and females to confirm reproducibility. Within this subset, fluorescent in situ hybridization (FISH) was used to localize decreases in the Syt1 and Slc6a3 transcripts to pSyn inclusion-containing neurons. Identification of transcriptional changes in early synucleinopathy provides insight into the molecular mechanisms driving neurodegeneration.
first_indexed 2024-03-08T16:22:30Z
format Article
id doaj.art-8bde4016617e4debb09532f2fc4a2cc0
institution Directory Open Access Journal
issn 2373-8057
language English
last_indexed 2024-03-08T16:22:30Z
publishDate 2024-01-01
publisher Nature Portfolio
record_format Article
series npj Parkinson's Disease
spelling doaj.art-8bde4016617e4debb09532f2fc4a2cc02024-01-07T12:17:09ZengNature Portfolionpj Parkinson's Disease2373-80572024-01-0110111710.1038/s41531-023-00620-yTranscriptomic profiling of early synucleinopathy in rats induced with preformed fibrilsJoseph R. Patterson0Joseph Kochmanski1Anna C. Stoll2Michael Kubik3Christopher J. Kemp4Megan F. Duffy5Kajene Thompson6Jacob W. Howe7Allyson Cole-Strauss8Nathan C. Kuhn9Kathryn M. Miller10Seth Nelson11Christopher U. Onyekpe12John S. Beck13Scott E. Counts14Alison I. Bernstein15Kathy Steece-Collier16Kelvin C. Luk17Caryl E. Sortwell18Department of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityDepartment of Translational Science and Molecular Medicine, Michigan State UniversityCenter for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of MedicineDepartment of Translational Science and Molecular Medicine, Michigan State UniversityAbstract Examination of early phases of synucleinopathy when inclusions are present, but long before neurodegeneration occurs, is critical to both understanding disease progression and the development of disease modifying therapies. The rat alpha-synuclein (α-syn) preformed fibril (PFF) model induces synchronized synucleinopathy that recapitulates the pathological features of Parkinson’s disease (PD) and can be used to study synucleinopathy progression. In this model, phosphorylated α-syn (pSyn) inclusion-containing neurons and reactive microglia (major histocompatibility complex-II immunoreactive) peak in the substantia nigra pars compacta (SNpc) months before appreciable neurodegeneration. However, it remains unclear which specific genes are driving these phenotypic changes. To identify transcriptional changes associated with early synucleinopathy, we used laser capture microdissection of the SNpc paired with RNA sequencing (RNASeq). Precision collection of the SNpc allowed for the assessment of differential transcript expression in the nigral dopamine neurons and proximal glia. Transcripts upregulated in early synucleinopathy were mainly associated with an immune response, whereas transcripts downregulated were associated with neurotransmission and the dopamine pathway. A subset of 29 transcripts associated with neurotransmission/vesicular release and the dopamine pathway were verified in a separate cohort of males and females to confirm reproducibility. Within this subset, fluorescent in situ hybridization (FISH) was used to localize decreases in the Syt1 and Slc6a3 transcripts to pSyn inclusion-containing neurons. Identification of transcriptional changes in early synucleinopathy provides insight into the molecular mechanisms driving neurodegeneration.https://doi.org/10.1038/s41531-023-00620-y
spellingShingle Joseph R. Patterson
Joseph Kochmanski
Anna C. Stoll
Michael Kubik
Christopher J. Kemp
Megan F. Duffy
Kajene Thompson
Jacob W. Howe
Allyson Cole-Strauss
Nathan C. Kuhn
Kathryn M. Miller
Seth Nelson
Christopher U. Onyekpe
John S. Beck
Scott E. Counts
Alison I. Bernstein
Kathy Steece-Collier
Kelvin C. Luk
Caryl E. Sortwell
Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils
npj Parkinson's Disease
title Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils
title_full Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils
title_fullStr Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils
title_full_unstemmed Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils
title_short Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils
title_sort transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils
url https://doi.org/10.1038/s41531-023-00620-y
work_keys_str_mv AT josephrpatterson transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT josephkochmanski transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT annacstoll transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT michaelkubik transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT christopherjkemp transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT meganfduffy transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT kajenethompson transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT jacobwhowe transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT allysoncolestrauss transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT nathanckuhn transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT kathrynmmiller transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT sethnelson transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT christopheruonyekpe transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT johnsbeck transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT scottecounts transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT alisonibernstein transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT kathysteececollier transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT kelvincluk transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils
AT carylesortwell transcriptomicprofilingofearlysynucleinopathyinratsinducedwithpreformedfibrils